C12N 2760/00033
Use of viral protein as therapeutic agent other than vaccine
Official title: Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory
C12N2760/00033 (Use of viral protein as therapeutic agent other than vaccine) appears on 3 US grants and 4 published applications in this corpus.
Search patents in C12N- Granted patents
- 3
- Published applications
- 4
- Assignees
- 8
- Inventors
- 6
- Latest grant
- 28 Aug 2018
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 1 | 0 |
| 2014 | 0 | 1 |
| 2015 | 0 | 0 |
| 2016 | 1 | 0 |
| 2017 | 0 | 1 |
| 2018 | 1 | 1 |
By publication year.
Recent patents
- Pharmaceutical compositions for prevention or treatment of neurodegenerative diseases28 Aug 2018US 10,059,748 B2Centre National de la Recherche Scientifique (CNRS)
- Influenza inhibiting compositions and methods31 May 2016US 9,353,157 B2Autoimmune Technologies, LLC
- Influenza inhibiting compositions and methods10 Dec 2013US 8,604,165 B2Autoimmune Technologies, LLC
- Pharmaceutical compositions for prevention or treatment of neurodegenerative diseases15 Nov 2018US 2018/0327458 A1Centre National de la Recherche Scientifique (CNRS)
- Pharmaceutical compositions for prevention or treatment of neurodegenerative diseases18 May 2017US 2017/0137472 A1Centre National de la Recherche Scientifique (CNRS)
- Influenza inhibiting compositions and methods10 Jul 2014US 2014/0194347 A1Autoimmune Technologies, LLC
- Influenza inhibiting compositions and methods17 Jun 2010US 2010/0152109 A1Autoimmune Technologies, LLC
Most cited
By later US patents